Interparfums designs, manufactures under licence and distributes fragrances for prestige brands, including Lacoste, Abercrombie & Fitch, Jimmy Choo, Montblanc and Van Cleef & Arpels, and it owns its own Rochas and Oscar de la Renta lines. The model is licence-heavy, which keeps capital needs light: operating margin sits at 21.1% on a 65.8% gross margin, and ROE is 17.1%. Revenue fell 7.3% in the latest reported period, so the question is whether that is cyclical destocking or a loss of brand momentum, and the answer will decide whether the 23.8x forward multiple (against 25.9x trailing) is undemanding for a business this profitable. The name is worth a deeper look to see how much of the top-line decline is wholesale inventory correction versus sell-through, and whether the licence portfolio is being renewed or rolled off. It carries no index membership, which may keep it under the radar of passive flows and leaves room for mispricing around any recovery in orders.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 23 Oct 2026, 01:53 CEST | ACCE price target | €31.90 | first publication | €34.50 |
| 22 Oct 2026, 12:04 CEST | Fair value | €23.72 | first publication | €32.44 |
| 22 Oct 2026, 12:04 CEST | Rating | Overvalued | first publication | €32.44 |
Answered from Interparfums SA fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| ITP.PA Interparfums SA | €34.36 | €24 | 45% above | 25.8x | 17.1% | 83 | 59 |
| 4967.T Kobayashi Pharmaceutical Co., Ltd. | ¥7150.00 | - | - | 327.1x | 0.8% | 46 | 47 |
| 4912.T Lion Corporation | ¥1831.00 | - | - | 17.7x | 9.7% | 67 | 70 |
| IPAR Interparfums Inc. Common Stock | $116.07 | $96 | 21% above | 22.0x | 19.1% | 77 | 62 |
| COTY Coty Inc. Class A Common Stock | $3.21 | $5 | 32% below | - | -16.1% | 38 | 47 |
| 4527.T Rohto Pharmaceutical Co.,Ltd. | ¥2851.50 | - | - | 20.0x | 10.9% | 67 | 66 |
| COLPAL.NS Colgate-Palmolive (India) Limited | ₹1685.00 | - | - | 32.1x | - | 100 | 52 |
Where ITP.PA ranks against its sector peers on each metric.